Ajax loader

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for:

INDIA-DRUGS/ANALYSIS
RTR2ZA0R 
March 13, 2012 
A pharmacologist checks the reaction of cytotoxic drugs inside the containment facility at Natco Research... 
Hyderabad, India 
A pharmacologist checks the reaction of cytotoxic drugs inside the containment facility at Natco Research... 
A pharmacologist checks the reaction of cytotoxic drugs inside the containment facility at Natco Research Centre in the southern Indian city of Hyderabad March 13, 2012. India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say. On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug cheaply in India. REUTERS/Krishnendu Halder (INDIA - Tags: HEALTH BUSINESS) 
Sort by 
Display 
Items per page 
Page 
of 1